Classic Hodgkin lymphoma pathology: what the report means

The report may describe Hodgkin or Reed-Sternberg cells, but their appearance alone is not enough. The pathologist combines the tissue architecture, background inflammation, cell markers, and clinical information before giving a final diagnosis.

Immunohistochemistry uses stains to show proteins within cells. In classic Hodgkin lymphoma, the abnormal cells commonly show a characteristic combination of markers, while some markers expected in other lymphomas are absent or only weakly expressed. Interpretation depends on the complete pattern rather than one positive stain.

A report may name a microscopic subtype or mention fibrosis, nodules, mixed inflammatory cells, or infection-related testing. These details refine classification. They do not, by themselves, show how far the lymphoma has spread; imaging, examination, and other tests establish stage.

Review whether the sample was sufficient and whether the diagnosis is final. A whole lymph-node or larger tissue sample may preserve architecture better than a small needle sample, although the suitable approach depends on the node location and procedure risk. If wording is uncertain, the team may request more tissue or specialist pathology review.

After confirmation, care planning brings the pathology together with symptoms, blood tests, and imaging. Treatment may include chemotherapy, radiotherapy, or another approach based on stage and individual circumstances. Discuss fertility preservation before treatment when future fertility matters, because some therapies can affect reproductive function.

Contact your clinical team promptly if a lymph node continues to enlarge, or if you develop persistent fever, drenching night sweats, unexplained weight loss, worsening itch, or increasing fatigue. Seek urgent care for trouble breathing, chest pressure, facial or neck swelling, fainting, confusion, or rapidly worsening illness. These features need assessment because they can reflect pressure on nearby structures, infection, or another serious problem.

Ask whether the tissue confidently supports classic Hodgkin lymphoma, which marker pattern led to the conclusion, whether a subtype was identified, and whether any result remains pending. Also ask what staging tests come next, how treatment choices relate to your health and priorities, and whether fertility planning should happen before therapy begins.